204 related articles for article (PubMed ID: 34175049)
1. Genome editing in stem cells for genetic neurodisorders.
Dell' Amico C; Tata A; Pellegrino E; Onorati M; Conti L
Prog Mol Biol Transl Sci; 2021; 182():403-438. PubMed ID: 34175049
[TBL] [Abstract][Full Text] [Related]
2. Disease Modeling of Neuropsychiatric Brain Disorders Using Human Stem Cell-Based Neural Models.
Kaindl J; Winner B
Curr Top Behav Neurosci; 2019; 42():159-183. PubMed ID: 31407242
[TBL] [Abstract][Full Text] [Related]
3. Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models.
Taoufik E; Kouroupi G; Zygogianni O; Matsas R
Open Biol; 2018 Sep; 8(9):. PubMed ID: 30185603
[TBL] [Abstract][Full Text] [Related]
4. Induced pluripotent stem cells (iPSCs) as game-changing tools in the treatment of neurodegenerative disease: Mirage or reality?
Yousefi N; Abdollahii S; Kouhbanani MAJ; Hassanzadeh A
J Cell Physiol; 2020 Dec; 235(12):9166-9184. PubMed ID: 32437029
[TBL] [Abstract][Full Text] [Related]
5. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
Corti S; Faravelli I; Cardano M; Conti L
Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
[TBL] [Abstract][Full Text] [Related]
6. Use of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platform.
Garcia-Leon JA; Vitorica J; Gutierrez A
Future Med Chem; 2019 Jun; 11(11):1305-1322. PubMed ID: 31161803
[TBL] [Abstract][Full Text] [Related]
7. Neural Stem Cells and Human Induced Pluripotent Stem Cells to Model Rare CNS Diseases.
De Filippis L; Zalfa C; Ferrari D
CNS Neurol Disord Drug Targets; 2017; 16(8):915-926. PubMed ID: 28641519
[TBL] [Abstract][Full Text] [Related]
8. Brain organoids: A revolutionary tool for modeling neurological disorders and development of therapeutics.
Acharya P; Choi NY; Shrestha S; Jeong S; Lee MY
Biotechnol Bioeng; 2024 Feb; 121(2):489-506. PubMed ID: 38013504
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
Prem S; Millonig JH; DiCicco-Bloom E
Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
[TBL] [Abstract][Full Text] [Related]
10. Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders.
Raikwar SP; Kikkeri NS; Sakuru R; Saeed D; Zahoor H; Premkumar K; Mentor S; Thangavel R; Dubova I; Ahmed ME; Selvakumar GP; Kempuraj D; Zaheer S; Iyer SS; Zaheer A
J Neuroimmune Pharmacol; 2019 Dec; 14(4):608-641. PubMed ID: 31011884
[TBL] [Abstract][Full Text] [Related]
11. Reaching into the toolbox: Stem cell models to study neuropsychiatric disorders.
Whiteley JT; Fernandes S; Sharma A; Mendes APD; Racha V; Benassi SK; Marchetto MC
Stem Cell Reports; 2022 Feb; 17(2):187-210. PubMed ID: 35063127
[TBL] [Abstract][Full Text] [Related]
12. Using Patient-Derived Induced Pluripotent Stem Cells to Model and Treat Epilepsies.
Du X; Parent JM
Curr Neurol Neurosci Rep; 2015 Oct; 15(10):71. PubMed ID: 26319172
[TBL] [Abstract][Full Text] [Related]
13. Neural stem cell-based treatment for neurodegenerative diseases.
Kim SU; Lee HJ; Kim YB
Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
[TBL] [Abstract][Full Text] [Related]
14. Modern Genome Editing Technologies in Huntington's Disease Research.
Malankhanova TB; Malakhova AA; Medvedev SP; Zakian SM
J Huntingtons Dis; 2017; 6(1):19-31. PubMed ID: 28128770
[TBL] [Abstract][Full Text] [Related]
15. Modeling human neurological disorders with induced pluripotent stem cells.
Imaizumi Y; Okano H
J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589
[TBL] [Abstract][Full Text] [Related]
16. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
Wu YY; Chiu FL; Yeh CS; Kuo HC
Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem cells for modeling neurological disorders.
Russo FB; Cugola FR; Fernandes IR; Pignatari GC; Beltrão-Braga PC
World J Transplant; 2015 Dec; 5(4):209-21. PubMed ID: 26722648
[TBL] [Abstract][Full Text] [Related]
18. Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases.
Cao L; Tan L; Jiang T; Zhu XC; Yu JT
Mol Neurobiol; 2015 Aug; 52(1):244-55. PubMed ID: 25146848
[TBL] [Abstract][Full Text] [Related]
19. Genome editing in pluripotent stem cells: research and therapeutic applications.
Deleidi M; Yu C
Biochem Biophys Res Commun; 2016 May; 473(3):665-74. PubMed ID: 26930470
[TBL] [Abstract][Full Text] [Related]
20. Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia.
Albert K; Niskanen J; Kälvälä S; Lehtonen Š
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
